The RAS is intricately linked to initial infection and possibly the progression of COVID-19 through a RAS receptor, angiotensin-converting enzyme 2 (ACE2), which acts as the viral entry point of coronavirus SARS-CoV-2 (Wiese et al., 2020; Li et al., 2003). This evidence concerns the gene ACE2 and infection.